Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma

Overview of attention for article published in American Journal of Health-System Pharmacy, June 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet

twitter: 9 X users

Readers on

mendeley: 68 Mendeley

So far, Altmetric has seen 11 X posts from 9 X users, with an upper bound of 55,612 followers.

While levalbuterol holds no advantage for most critically ill patients, it is a viable, albeit more expensive, option. Equivalent levalbuterol dosing is half the albuterol dose: levalbuterol 1.25 mg = albuterol 2.5 mg. https://t.co/ECbqNdjXuU, https://t…

@Floresdelaurel @DraGranadilla @MriaCa @DotorJaimito Ajunto las referencias https://t.co/hNqhDdjYOg ASMA pediatrico, https://t.co/8IeY0bTQJv EPOC y asma adulto 😁, como no es superior al salbutmol, con salbutamol se haria lo mismo.

https://t.co/kOhcIZTgAe

Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with… https://t.co/af2eS2wQyS

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.